NHS Midlands & East Framework for Denosumab 60mg PFS

NHS Midlands & East is seeking suppliers for Denosumab 60mg pre-filled syringes under a regional framework agreement. The contract runs from January to August 2027 with an option to extend by up to 16 months.

View on Find a Tender →

Closed13 October 2026, 13:00
Published18 September 2026
Value£600k
BuyerNHS England
WhereNHS Midlands & East region
CategoryHealth & medical
RegionEast Midlands, East of England, West Midlands

You'll want to look if you're a pharmaceutical wholesaler or manufacturer with the ability to supply Denosumab 60mg PFS into NHS Midlands & East trusts.

Possible incumbent

Accord-UK Ltd, Celltrion Healthcare United Kingdom Limited, Gedeon Richter UK Ltd, Teva UK Limited, Zentiva Pharma UK Ltd, Fresenius Kabi Limited, and Amgen Ltd won the NHS National Framework for Denosumab Injection from 1 January 2026. Inferred from prior awards to this buyer, not confirmed.